August 16, 2023 — A new American Heart Association (AHA) scientific statement highlights evidence that supports shared decision-making, a term that describes the process of ensuring patients have the knowledge and tools to make decisions about their health in collaboration with their professional health care team.

August 16, 2023 —Moderate or extreme pain after a heart attack – most commonly pain due to other health conditions – may help predict the likelihood of death over the next 8.5 years, according to newly-published research in the Journal of the American Heart Association, JAHA. People who have had a heart attack often report pain about a year later.

DAIC’s award-winning editorial team delivers industry trends and technology information to the professionals who make purchasing decisions. DAIC maintains a comprehensive listing of cardiology specialty meetings, events and educational summits on its website at www.dicardiology.com/events. Find the dates, location and links to cardiology conferences in one location.

Virtual CTA Academy: Cardiac CT for the Practitioner: A comprehensive foundation course

August 15, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced it has received a De Novo approval by the U.S. Food and Drug Administration (FDA) for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, creating a new regulatory category for cardiovascular machine learning-based notification software.

August 15, 2023 — There is new evidence that bolsters a possible link between e-cigarette use and increased risk of stroke, according to researchers from the University of Colorado Boulder. Their study conducted in humans showed that circulating endothelial cell-derived microvesicles (tiny, bubble-like particles released into the bloodstream during inflammation) from e-cigarette users have adverse effects on key factors responsible for regulating brain blood flow.

August 15, 2023  — Argus Cognitive, Inc., a digital health company that develops software medical devices, announced that it has been granted U.S. Food and Drug Administration (FDA) 510k clearance for its 3D echocardiography-based product.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now